tiprankstipranks
Zelira Therapeutics (ZLDAF)
OTHER OTC:ZLDAF
US Market
ZLDAF
Zelira Therapeutics
RESEARCH TOOLSreports
Want to see ZLDAF full AI Analyst Report?

Zelira Therapeutics (ZLDAF) Income Statement

16 Followers

Zelira Therapeutics Income Statement

Last quarter (Q4 2025), Zelira Therapeutics's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Zelira Therapeutics's net income was AU$-1.22M. See Zelira Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 21
Total Revenue
AU$ 656.00AU$ 94.95KAU$ 301.12KAU$ 1.54MAU$ 663.32K
Gross Profit
AU$ -802.95KAU$ 10.28KAU$ -3.22MAU$ -5.72MAU$ -39.16K
Operating Expenses
AU$ 3.15MAU$ 5.95MAU$ 6.17MAU$ 7.70MAU$ 9.61M
Depreciation and Amortization
AU$ 147.05KAU$ 479.04KAU$ 545.22KAU$ 588.54KAU$ 474.25K
EBITDA
AU$ -4.17MAU$ -36.44MAU$ -6.79MAU$ -13.06MAU$ -9.41M
Operating Income
AU$ -3.95MAU$ -5.94MAU$ -7.41MAU$ -13.41MAU$ -9.65M
Other Income/Expenses
AU$ 102.52KAU$ -30.80MAU$ 1.29KAU$ -290.82KAU$ -275.31K
Pretax Income
AU$ -3.85MAU$ -36.74MAU$ -7.41MAU$ -13.71MAU$ -9.93M
Net Income
AU$ -3.63MAU$ -36.57MAU$ -5.57MAU$ -11.95MAU$ -8.55M
Per Share Metrics
Basic EPS
AU$ -0.32AU$ -3.22AU$ -0.55AU$ -1.49AU$ -1.29
Diluted EPS
AU$ -0.32AU$ -3.22AU$ -0.55AU$ -1.49AU$ -1.29
Weighted Average Shares Outstanding
 11.48M 11.35M 10.07M 8.04M 6.63M
Weighted Average Shares Outstanding (Diluted)
 11.48M 11.35M 10.07M 8.04M 6.63M
Currency in AUD

Zelira Therapeutics Earnings and Revenue History